Allogene Therapeutics (ALLO) Sɔɔtɔ Fɔrɛkɛst

Allogene Therapeutics

Healthcare · USD · United States of America

TG WA X in ⧉

Nɔnyɔ nyɛ$1.65Nɔɔ 25 Gbo 2026 19:59 UTC

Nyuɛ-1.20%

AI forecast: ALLO

1 ŋwɛ

$1.65

🔒 Unlock Premium

1 ɛtɛ

$1.65

🔒 Unlock Premium

1 ɔdɔ

$1.65

🔒 Unlock Premium

AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.

Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ

Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.

Unlock Premium

🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ

The forecast track record — every past forecast next to the actual close — is part of Premium.

Unlock Premium

Ɛŋɛ Nɛ Kɔmpɔni A

Allogene Therapeutics, Inc. is a biotechnology company that develops T-cell therapies using allogeneic chimeric antigen receptors for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in California.

Stocks Lɛ Nɔ

TXG10X Genomics Inc Nɔnyɔ nyɛ$85.71 +1.90%AI forecast · 1 ŋwɛ🔒 Premium ABTAbbott Nɔnyɔ nyɛ$101.31 +0.24%AI forecast · 1 ŋwɛ🔒 Premium ABBVAbbVie Nɔnyɔ nyɛ$264.31 -0.31%AI forecast · 1 ŋwɛ🔒 Premium ABCLAbCellera Biologics Nɔnyɔ nyɛ$12.72 +0.47%AI forecast · 1 ŋwɛ🔒 Premium ACADACADIA Pharmaceuticals Inc Nɔnyɔ nyɛ$20.68 -6.76%AI forecast · 1 ŋwɛ🔒 Premium ACMRACM Research Inc Nɔnyɔ nyɛ$77.34 +1.52%AI forecast · 1 ŋwɛ🔒 Premium ADAPAdaptimmune Therapeutics АДР Nɔnyɔ nyɛ$0.03 +50.00%AI forecast · 1 ŋwɛ🔒 Premium ADPTAdaptive Biotechnologies Nɔnyɔ nyɛ$29.45 -0.41%AI forecast · 1 ŋwɛ🔒 Premium

Get AI Stock Predictions Now

Kɛ ni app ni ni AI stock forecasts ni iPhone, Android ni Windows

Unlock Premium

Disclaimer: AI-generated stock predictions are for informational purposes only and do not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions. Investing involves risk, including possible loss of principal.